one to the other that is abnormal, with an excess of T4+ cells.6 It was further shown that within these T4+ lymphocyte clusters non-lymphoid dendritic cells occurred in abnormally large numbers.7 These dendritic cells were shown to have the phenotype of interdigitating cells, a cell type normally residing in the T cell areas of lymph nodes and thought to be responsible for antigen presentation and the induction of immune responses.4 Such observations add weight to the hypothesis that the basis of the chronicity of RA associated inflammation is the result of a local breakdown of lymphocyte/ macrophage immunoregulation.8 Further evidence in support of the suggestion that this is a local phenomenon comes from the examination of synovial tissue from osteoarthritic patients and rheumatoid nodules taken from RA patients. In osteoarthritis (OA) the immunohistological analysis found only few T cells, with T4+/T8+ ratios normal and a marked absence of interdigitating cells. 4 5 Again within the rheumatoid nodules the immunopathological picture did not reflect that seen in the 584 synovium. 4 9 More recently, similar immunohistolo- gical studies showed that a significant proportion of T lymphocytes within the synovial stroma of patients with rheumatoid arthritis expressed signs of activation.5 With monoclonal antibodies directed against class II major histocompatibility complex (MHC) antigens and a P40 antigen preferentially expressed on T blasts (McAbs RFDR2 and RFT2 respectively) it was found that 25% of T cells in this inflamed tissue were RFT2 positive, and all of these RFT2 cells were RFDR2+. Furthermore, all of these activated cells were present in the synovia of patients with RA, anklosing spondylitis (AS), and psoriatic arthritis but not present on degenerative arthropathies or in rheumatoid nodules.5 These observations and those relating to the interdigitating cells referred to earlier offer cogent evidence in support of the hypothesis that inflammatory arthritis can be clearly distinguished on immunohistological grounds from degenerative arthropathies where no immunohistopathological evidence of local immunoregulatory dysfunction is present.
Such studies, however, demand the use of arthroscopic biopsy to obtain tissue for analysis. As this procedure is not always available and indeed may result in a degree of morbidity the present study concentrated on an analysis of cells within synovial fluid, which may be obtained repeatedly by aspiration. Our intention was to determine whether similar cellular changes indicative of the ongoing disease process could be identified within the synovial fluids obtained from patients presenting with clinically defined arthropathies. Patients (Fig. 3) showed that significantly higher proportions of T cells were activated in the SF of rheumatoid patients (mean 25%, seropositive; 18%, seronegative) than were seen in OA SFs (2-5%) and in traumatic knees (mean <1%) (p<0-01 in both cases).
PROPORTIONS OF SUBSETS OF MACROPHAGE LIKE CELLS
Cytospins of SF cells from all groups were subsequently analysed with McAbs, RFD7 and RFD1, and the proportions of positive cells were recorded. RFD7 identifies mature 'classical' macrophages, while RFD1 identifies interdigitating cells (ID cells, see Table 1 ). A lysosomal acid phosphatase (ACP) reaction was also performed on some cytospins. This histochemical reaction is positive on all monocytes/macrophages but negative on ID cells. corded after steroid treatment, but no effect was seen on the proportion of RFD1+ cells. The follow up in this last case is as yet too short for any firm conclusions to be drawn. Indeed these results are presented as preliminary observations.
Discussion
The data presented in this paper show the presence of activated T cells and dendritic cells with the phenotype of antigen presenting interdigitating cells within the SF of patients with RA, and in other inflammatory arthropathies. These populations were not identified in any significant numbers in patients with degenerative OA or in effusions taken from traumatised knees. On the other hand, differential cell counts or the quantification of T4/T8 ratios failed to discriminate between these patient groups.
There is now increasing evidence that the pathogenic tissue changes associated with inflammatory arthritis stem from dysfunction of macrophage/ lymphocyte immunoregulation.8 This suggestion has been strengthened by the observation that the T cell infiltrates of the synovial tissue contain a disproportionately large number of the T4+ subset,6 and that large dendritic cells expressing high concentrations of class II MHC antigens are present in close association with these cells.7 More recently it has been observed that many T cells within the inflamed synovia are activated.5 As it has also been reported that interleukin-2 (IL-2) production of The immunohistological studies that showed these abnormal cellular associations in inflammatory arthritic synovia also confirmed that no similar changes occur in the synovium of patients with degenerative arthropathies.5 Furthermore, similar studies of rheumatoid nodules from RA patients showed that the abnormalities seen within the synovial membranes were not reflected in these nodules. In the cases where immunocytochemical analysis was repeated after treatment with intra-articular steroids the numbers of both activated T cells and dendritic cells were both found to be reduced in one case, unchanged in another, and with a reduction seen only in RFT2+ cells in a third. All these observations were made at times when no clinical improvement was manifest. Although the one case where reductions in both immunocompetent cell types were seen has subsequently improved, it is far too early to draw any conclusions. We feel, however, that these preliminary results on repeat aspirations warrant further investigation.
With regard to the direct immunocytological investigation of SF samples, however, we conclude that this analysis may offer some diagnostic or prognostic indication of the immunological basis of the ongoing arthropathy. Furthermore, the similar results obtained with seropositive and seronegative patients suggest that this serological distinction may have no direct bearing on the inflammatory process in the joint. 
